ACR Sets 2021 Policy Priorities for Congress, Biden Administration

January 27th 2021, 1:46pm


The American College of Rheumatology (ACR) announced a number of policy priorities that it is encouraging the new Congress and administration to focus on during the year.

Researchers Try to Replicate Secukinumab, Ustekinumab Study With Registry Data

January 25th 2021, 8:15pm


The study sought to understand how psoriasis treatments perform in real-world settings.

CMS Finalizes Rule on Electronic Prior Authorization

January 15th 2021, 9:58pm


CMS finalized a rule on electronic data entry that will streamline the prior authorization process and improve data transparency for providers, payers, and patients.

Study Identifies Potential New Biomarkers of ILD in Rheumatoid Arthritis

January 6th 2021, 6:59pm


Study findings, published in Frontiers in Medicine, underscore the importance of metabolic profiling for discovering candidate screening biomarkers for interstitial lung disease (ILD) in rheumatoid arthritis.

Psoriatic Arthritis, Rheumatoid Arthritis Cause Similar Hand Impairment, but So Does Psoriasis

December 31st 2020, 2:00pm


In an unexpected finding, patients with psoriasis showed similar hand impairment to patients with psoriatic arthritis and rheumatoid arthritis.

Depression Prevalence Found to Be Higher in PsA Than RA, Diabetes

December 29th 2020, 12:15pm


A Greek study examined the prevalence of comorbidities in patients with rheumatoid arthritis (RA), diabetes, and psoriatic arthritis (PsA).

Secukinumab Improves Signs, Symptoms of Axial Disease in Patients With PsA

December 24th 2020, 4:30pm


Both secukinumab 300 mg and secukinumab 150 mg significantly improved signs and symptoms of axial disease in patients with psoriatic arthritis (PsA) who had inadequate response to non- steroidal anti-inflammatory drugs.

Study Examines Activity Levels in Patients With Psoriatic Arthritis

December 12th 2020, 6:00pm


The study showed that that patients with higher disease activity had significantly lower levels of physical activity.

Rheumatoid Arthritis Medication Adherence in a Health System Specialty Pharmacy

December 12th 2020, 1:00pm


Integrated health system specialty pharmacies provide specialized services to patients, resulting in high rates of adherence to and financial assistance with specialty disease-modifying antirheumatic drugs.

Secukinumab Has a Greater Persistence Rate Than Ustekinumab in Psoriatic Arthritis

December 5th 2020, 5:15pm


In the real world, the persistence rate with secukinumab to treat psoriatic arthritis was higher than with ustekinumab.